Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Suspended × Colonic Neoplasms × Clear all

Phase

Phase NA 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Completed 183 Terminated 44 Unknown 41 Recruiting 34 Withdrawn 16 Not yet recruiting 15 Active not recruiting 9 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 8 Melanoma 6 Carcinoma, Non-Small-Cell Lung 5 Stomach Neoplasms 4 Neoplasm Metastasis 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Neoplasms 3 Leukemia, Myeloid, Acute 3 Carcinoma, Renal Cell 3 Rectal Neoplasms 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Lymphoma, Follicular 2 Lymphoma 2 Lung Neoplasms 2 Glioblastoma 2 Diffuse Intrinsic Pontine Glioma 2 Breast Neoplasms 2 Warts 1 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Adenocarcinoma 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Recurrent Head and Neck Carcinoma 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Phase 2 Study 1 Peritoneal Neoplasms 1

Interventions

tucatinib 1 trifluridine tipiracil drug combination 1 Trastuzumab 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05062889 2026-02-03

ERASE-CRC

Gruppo Oncologico del Nord-Ovest

Phase 2 Suspended

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡